home / lobbying / lobbying_activities

lobbying_activities: 2797589

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2797589 f123561b-bc62-4d3d-a46f-1b5c3062a846 Q1 CAMPAIGN FOR TOBACCO-FREE KIDS 27401 CAMPAIGN FOR TOBACCO-FREE KIDS 2022 first_quarter TOB Lobbying Report: January 1 - March 31, 2022 Legislation: H.R. 2471 Consolidated Appropriations Act, 2022 House FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) House FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) Senate FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and regulation of tobacco products) Senate FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) H.R. 2125 Quit Because of COVID-19 Act H.R. 6286 Clarifying Authority over Nicotine Act H.R. ____ Health Equity and Accountability Act S. ____ Reversing the Youth Tobacco Epidemic Act Issues: Dr. Robert Califf nomination for FDA Commissioner FDA action to address synthetic nicotine FDA regulation of menthol cigarettes and flavored cigars FDA premarket review of e-cigarettes Tobacco cessation in general Tobaccos role in health disparities Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Food and Drug Administration Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   402000 0 0 2022-04-20T14:20:08-04:00
Powered by Datasette · Queries took 0.316ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API